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In vitro models of Chlamydia trachomatis growth have long been studied to predict growth
in vivo. Alternative or persistent growth modes in vitro have been shown to occur under
the influence of numerous stressors but have not been studied in vivo. Here, we report
the development of methods for sampling human infections from the endocervix in a
manner that permits a multifaceted analysis of the bacteria, host and the endocervical
environment. Our approach permits evaluating total bacterial load, transcriptional patterns,
morphology by immunofluorescence and electron microscopy, and levels of cytokines
and nutrients in the infection microenvironment. By applying this approach to two pilot
patients with disparate infections, we have determined that their contrasting growth
patterns correlate with strikingly distinct transcriptional biomarkers, and are associated
with differences in local levels of IFNγ . Our multifaceted approach will be useful to
dissect infections in the human host and be useful in identifying patients at risk for
chronic disease. Importantly, the molecular and morphological analyses described here
indicate that persistent growth forms can be isolated from the human endocervix when
the infection microenvironment resembles the in vitro model of IFNγ -induced persistence.
Keywords: bacterial persistence, Chlamydia trachomatis, endocervix, human, interferon gamma, indole
INTRODUCTION
Chlamydia trachomatis is an obligate intracellular bacterium and
serovars D-K are tropic for the columnar and transitional epithe-
lial cells of the genital tract. Chlamydial infections in women
are generally asymptomatic and therefore often go undetected
and untreated (Brunham and Rey-Ladino, 2005). Natural his-
tory studies indicate untreated infections can be asymptomatic
for substantial periods of time, can spontaneously resolve or
can progress to cause complications (Parks et al., 1997; Golden
et al., 2000; Joyner et al., 2002; Morre et al., 2002; Molano et al.,
2005; Geisler et al., 2008). Infection most commonly occurs in
the endocervix and can result in cervicitis. If bacteria ascend
into the endometrium and Fallopian tubes chronic infection can
lead to pelvic inflammatory disease (PID). Approximately 11% of
women with PID will subsequently develop tubal factor infertil-
ity, but, as many of these infections are also clinically silent, they
also remain undiscovered until reproductive consequences ensue
(Cohen and Brunham, 1999).
Why so many chlamydial infections are so extended in their
duration is not well understood, but does indicate the organism
is capable of adapting to, or evading, specific immune and envi-
ronmental conditions (Brunham and Rey-Ladino, 2005). One
strategy documented in vitro for immune evasion or adaptation
in the human host is the ability of C. trachomatis to enter into
a persistent growth form (Beatty et al., 1994b; Belland et al.,
2003a). This bacterial form is viable but non-cultivable and
results in an extended relationship between the pathogen and
its host cell (ibid). Compelling, but thus far indirect evidence,
for this alternative mode of growth in vivo includes documen-
tation of recurrent disease when re-infection is unlikely, and the
detection of chlamydial antigen or nucleic acid in the absence
of cultivability (Nagasaki, 1987; Patton et al., 1994; Dean et al.,
2000).
Classic in vitro studies have shown C. trachomatis has a
unique developmental cycle that normally alternates between an
infectious elementary body (EB) and a non-infectious reticu-
late body (RB) (Abdelrahman and Belland, 2005). EBs attach
to, and invade, susceptible cells where they are internalized in
membrane bound vacuoles termed inclusions (ibid). EBs, now
known to possess some metabolic activity (Omsland et al., 2012),
then differentiate into highly metabolically active RBs, undergo
repeated cycles of binary fission and then differentiate back to
EBs whence they are released from the host cell by lysis or extru-
sion to infect neighboring cells (Abdelrahman and Belland, 2005;
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Hybiske and Stephens, 2007). The entire developmental cycle may
take 30–48 h, dependent on the serovar, with temporally distinct
patterns of gene expression categorized as early, mid-cycle and
late that correlate with C. trachomatis growth stages (Belland
et al., 2003b). Stressful growth conditions that are also likely to
be encountered in vivo can induce an alternate, persistent growth
mode in vitro (Wyrick, 2010). These stressors include, nutrient
and iron deprivation (Raulston, 1997; Igietseme et al., 1998), spe-
cific antibiotics (Matsumoto andManire, 1970; Clark et al., 1982),
co-infection with herpes simplex virus (HSV) (Vanover et al.,
2008), exposure of infected cells to the danger signal adenosine
(Pettengill et al., 2009), and interferon gamma (IFNγ ) (Beatty
et al., 1993), the latter of which, under optimal conditions, is
believed to be a key immune mediator in resolution of, and sub-
sequent protection from, infection(Rank and Whittum-Hudson,
2010; Aiyar et al., 2014). Persistent bacterial forms, induced by
IFNγ , are morphologically characterized as large, atypical, or
aberrant RBs in which binary fission appears to be arrested (Byrne
et al., 1986; Beatty et al., 1993, 1994b; Wyrick, 2010). Molecularly,
gene expression profiles associated with persistent forms are con-
sistent with RBs blocked in binary fission and arrest of the
developmental cycle at the stage just preceding late gene expres-
sion (Belland et al., 2003a). Removal of IFNγ generally reverses
these changes such that aberrant RB re-enter the developmen-
tal cycle and differentiate into infectious EBs. Well-characterized
in vitro models indicate that IFNγ acts against C. trachoma-
tis via nutrient deprivation (Beatty et al., 1993). Specifically,
IFNγ induces the tryptophan-catabolizing enzyme, indoleamine
2,3-dioxygenase (IDO1), thereby deprivingC. trachomatis, a tryp-
tophan auxotroph, of this essential amino-acid (Byrne et al., 1986;
Taylor and Feng, 1991; Beatty et al., 1994a,b). Depending on
the concentration and duration of exposure to IFNγ , and con-
sequently the environmental tryptophan levels, C. trachomatis
either enters into a persistent state of growth, or can be erad-
icated (Byrne et al., 1989). Importantly, genital serovars of C.
trachomatis can uniquely synthesize tryptophan through indole
salvage (Fehlner-Gardiner et al., 2002), suggesting that exogenous
sources of indole, likely microbial-derived in the natural environ-
ment, may extend or permit the survival of C. trachomatis in the
presence of IFNγ (Fehlner-Gardiner et al., 2002; Caldwell et al.,
2003; Aiyar et al., 2014).
While in vitro models have proven very insightful in eluci-
dating chlamydial growth modes under highly controlled condi-
tions, there have been no definitive studies that directly establish
whether persistent growth forms as described above are an in vivo
survival mechanism for C. trachomatis (Wyrick, 2010). In fact,
there is a paucity of information describing C. trachomatis growth
in the human genital tract milieu, the composition of this milieu,
how endogenous and exogenous co-factors alter the composi-
tion, and the resultant effects on C. trachomatis. Variability in
these co-factors may be critical in determining whether C. tra-
chomatis survives or is eradicated by host immune responses.
Addressing this gap in our knowledge will likely reveal the mech-
anisms by which C. trachomatis maintains in vivo reservoirs of
infection. It will also provide crucial normative data to aid in the
design of diagnostics, vaccines, and adjunct therapies that could
classify, target, and eliminate human C. trachomatis infections.
Therefore, the objective of the study described here was to develop
methodology to harvest, preserve, and analyze cells and secre-
tions from the human endocervix that would permit parallel
molecular and morphological analyses of C. trachomatis, along
with analyses of the immune and environmental milieu in which
it survives. Using this novel multifaceted approach, we were
able to identify highly contrasting patterns of bacterial growth,
and associated cervicovaginal environment factors, in two pilot
patients. These preliminary results indicate that this approach
may pave the way to the establishment of a biomarker panel
suitable for assessing chlamydial growth patterns and disease
outcomes of C. trachomatis infections in women. Importantly,
the contrasting molecular and morphological characteristics
observed in these two patients provide the first evidence for
the existence of persistent growth forms in the human genital
tract.
MATERIALS AND METHODS
STUDY POPULATION AND CLINIC PROCEDURES
Institutional Review Board approval for this study was obtained
from LSU Health Sciences Center. Women aged 18–28 years and
attending the Delgado STD Clinic were asked to participate and
then enrolled in this study if they had a high probability of
chlamydial infection based on the following criteria: a recent pos-
itive NAAT screening test for C. trachomatis; recent sexual contact
with a male suspected of chlamydial infection; or clinical evi-
dence of cervicitis. Exclusion criteria were as follows: pregnancy;
underlying chronic disease; use of steroids or antibiotics within
the last 2 weeks; sexual intercourse within the last 12 h; current
menstrual bleeding; documented infection with human immun-
odeficiency virus; or a history of genital herpes. Samples were
excluded from the analyses if women were C. trachomatis NAAT
or culture negative at the enrollment visit. All Chlamydia tra-
chomatis-infected women were treated with azithromycin at this
treatment/enrollment visit. Two groups of women were sequen-
tially enrolled into the study; variations in the cytobrush and/or
endocervical culture swab collection fluid or processing was the
only difference in the two groups.
SAMPLE COLLECTION
Pelvic samples were taken in the following order: (i) vaginal
swab for a wet mount and a Gram stain preparation; (ii) vagi-
nal swab placed in an InPouch (BioMed Diagnostics Inc.) for
Trichomonas vaginalis culture; (iii) two sequential cervical cyto-
brush samplings, each one as a gentle 360◦ sweep of the cervical
os, immersed in 1.5ml collection fluid; (iv) endocervical swab
immersed in endocervical transport medium (Ficarra et al., 2008)
in a one dram vial with glass beads for C. trachomatis culture and
genotyping; and (v) an endocervical swab for NAAT testing (ibid).
In study 1 (the inclusion identification study), cytobrushes were
immediately placed in a commercial transport fluid for liquid-
based Papanicalou (PAP) testing (SurePath by BD Diagnostics or
CytoLyt by Hologic). In study 2 (the ultrastructure and growth
biomarker study), three changes were made to the protocol as
follows: (1) cytobrushes were immediately immersed in a mod-
ified Electron Microscopy (EM) buffer (4% paraformeldehyde-
1% glutaraldehyde); (2) the endocervical swab in endocervical
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transport medium from patients in study 2 was immediately vor-
texed in clinic and 25% of the sample was removed and placed
in an equal volume of MasterPure tissue and cell lysis solu-
tion (Epicentre, Illumina); and (3) Merocel ophthalmic sponges
(Medtronic Xomed Inc.) were placed in the posterior fornix of
the vagina for 2min to absorb secretions (Kozlowski et al., 2000).
Sponges were immediately placed in cryovials and transported to
the laboratory on ice, after which they were stored at -80◦C until
vaginal fluid was extracted.
STD DIAGNOSTICS
Endocervical swab specimens were used to determine the pres-
ence of C. trachomatis and N. gonorrhoeae using the Aptima
Combo 2 test as instructed by the manufacturer (Genprobe). A
vaginal wet preparation was made in the clinic, and bacterial vagi-
nosis (BV) was later diagnosed by Gram stain, with a Nugent’s
score of >7 being positive (Nugent et al., 1991). InPouch cul-
ture for T. vaginalis screening was read at baseline, 48 and 72 h
(Ficarra et al., 2008). Swab specimens in endocervical medium
were immediately frozen until they were processed for semi-
quantitative culture for inclusion forming units (IFU) and for
genotyping of C. trachomatis, as previously described (ibid).
CYTOBRUSH PROCESSING
Cytobrushes from study 1 were centrifuged, resuspended in
500µl PBS, and concentrated endocervical cell preparations
were dropped into PAP-pen circumferenced circles on glass
slides, dried, fixed in 90% methanol for 10min and stored
at −20◦C until immunofluoresecent analyses (IFA) were per-
formed. Cytobrushes in modified EM buffer were vortexed,
washed twice, and resuspended in PBS, then cells were enumer-
ated. Twenty percent of the sample was used to make slides as
described above, and the remainder was further processed for EM
analysis if inclusions were noted on an IFA screen.
IMMUNOFLUORESCENT STAINING, COUNTING OF INCLUSIONS, AND
DECONVOLUTION MICROSCOPY
Cells on slides were rehydrated in PBS and incubated overnight at
4◦C with a blocking agent (Background Sniper, Biocare Medical).
Between 50 and 100% of each sample was used to count inclu-
sions in the inclusion identification study, depending on the
number of cells retrieved from the patient, and 100% was used
in the EM/Biomarker study. An anti-chlamydial LPS antibody
conjugated to fluorescein isothiocyanate (FITC) and which con-
tains Evans Blue as a counterstain (Merifluor, Meridian) was used
to visualize C. trachomatis forms; 4’,6 diamidino-2-phenylindole
(DAPI) was also applied to visualize nucleic acid (Molecular
Probes). Slides were cover-slipped with Prolong Gold antifade
reagent (Invitrogen) prior to the examination of inclusions. In
samples with larger numbers of cells, we also investigated the
expression of the chlamydial proteins OmcA and CT223. In
brief, following rehydration and blocking, samples were incu-
bated with Image-iT R FX Signal Enhancer followed by a mouse
monoclonal antibody to OmcA (1:750, B12K, a kind gift of
Dr. Li Shen) (Zhang et al., 1987) or a rabbit polyclonal anti-
CT223 at (1:500, CT223 186, a kind gift of Dr. Dan Rockey)
(Alzhanov et al., 2009). Samples were incubated with a sec-
ondary antibody (Alexa568 conjugated anti-mouse antibody or
Alexa 594 conjugated anti-rabbit antibody, 1:500, Molecular
Probes) followed by an anti-chlamydial LPS-FITC antibody (1:20,
YVS 1683, Accurate). Dual stained slides were finally counter-
stained and cover-slipped as described above. All images were
obtained with a Leica DMRXA automated upright epifluores-
cent microscope (Leica Microsystems); a Sensicam QE CCD
(Cooke Corporation); and filter sets optimized for Alexa 488
(exciter HQ480/20, dichroic Q495LP, and emitter HQ510/20m),
Alexa 568/594 (exciter HQ560/55x, dichroic Q595LP, and emitter
HQ645/75m) and DAPI (exciter 360/40x, dichroic 400DCLP, and
emitter GG420LP). Images were captured with a 63X objective
(NA= 1.42) and a 2× zoom. Z-axis plane capture, deconvolution,
and analysis were performed with Slidebook™ Deconvolution
Software (Intelligent Imaging Innovations, Denver, CO).
ULTRASTRUCTURAL ANALYSES
Cervical cell samples were post-fixed in 1% osmium tetroxide
(Polysciences Inc.) for 1 h as previously described (Belland et al.,
2003a). Samples were then rinsed extensively in deionized water
(dH20) prior to en bloc staining with 1% aqueous uranyl acetate
(Ted Pella Inc.) for 1 h. Following several rinses in dH20, samples
were dehydrated in a graded series of ethanol and embedded in
Eponate 12 resin (Ted Pella Inc.). Thick sections (200–300 nm)
obtained with a Leica Ultracut UCT ultramicrotome were stained
with toluidine blue for initial screening of tissue for inclusions
at the light microscopy level. Ultrathin sections of 95 nm were
stained with uranyl acetate and lead citrate for detailed ultra-
structural analyses of bacteria and inclusions on a JEOL 1200 EX
transmission electron microscope (JEOL USA Inc.). The bacte-
rial forms in identified inclusions were subsequently evaluated
using the scientific image processing and analysis program, Fiji
(Schindelin et al., 2012), as described here. After appropriately
setting the scale, the freehand selection tool was used to create a
rough outline of each inclusion. Image thresholding was used to
remove background pixel density within the inclusion. The par-
ticle analysis function was used to enumerate the number of EBs
per inclusion. Particles that were greater than 0.05µm2 with a cir-
cularity between 0.45 and 1.0 were enumerated. These parameters
identified immature EBs with an electron-dense core, electron
dense mature EBs, circular RBs, RBs undergoing binary fission,
and atypical RBs that were larger in size and displayed multiple
septum formation. For those inclusions in which the background
density did not permit a single threshold to be applied, an alter-
native procedure was used. Image thresholding was applied to the
outlined inclusions to reveal immature and mature EBs that were
sized for their areas. The following procedure was used to enu-
merate and size the RBs and atypical RBs. First, the thresholded
image containingmature/immature EBs was used to create amask
image in which all the EBs were outlined. This mask was sub-
tracted from the original micrograph to remove all EBs. A new
image threshold was now applied to subtract the background and
enumerate and size RBs and atypical RBs.
qPCR FOR C. TRACHOMATIS GENES AND GENOME COPY NUMBER
QUANTITATION
Endocervical swab samples in MasterPure lysis solution
(Epicenter, Illumina) were processed for total nucleic acid
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according to the manufacturers instructions and stored at −80◦C
until use. For each patient, 30% of each sample was used to
determine C. trachomatis genome copy number. RNA was
removed by digestion with RNaseA, the DNA was re-purified
by isopropanol precipitation and samples (150 ng/well) were
then analyzed by Taqman™ qPCR in triplicate, including a
no-template control, using an Applied Biosystems PRISM 7700
Sequence Detection System. The remaining total nucleic acid
was treated with DNase and re-precipitated. Each of the samples
was subjected to qRT-PCR using Taqman primer/probe sets
specific for the mRNAs encoded by the genes euo and omcB.
Equivalent amounts of RNA (20 ng) were used to measure
expression levels in triplicate and a no-RT control was included
for each primer/probe set. Normalization was performed using
C. trachomatis genome copy numbers, as previously described
(Ibana et al., 2011).
DETECTION OF IFNγ AND INDOLES IN VAGINAL SECRETIONS
Vaginal fluid was eluted fromMerocel sponges in a spin assembly
apparatus, and secretion volumes and dilution factors were cal-
culated as previously described for Weck-Cel sponges (Kozlowski
et al., 2000). Total protein was assayed using a Pierce BCA
protein assay kit (Thermo Fisher Scientific). IFNγ was quan-
tified by a cytometric bead array assay (MILLIPLEX MAP
Immunology Multiplex Assay). Millipore, Billerica, MA) as pre-
viously described (Buckner et al., 2011, 2013). Total indoles
were quantified using Salkowski’s test (Salkowski, 1885), mod-
ified as described by Szkop et al. (2012). In brief, an equimo-
lar mixture of multiple indoles (Sigma-Aldrich, Inc., St. Louis,
MO, USA) was used to generate a standard curve by mea-
suring absorbance at 530 nm after incubation with Salkowski’s
reagent. Indoles that can be detected by this test include indole,
3-methyl indole, indolic acids, and indolic alcohols. Samples
were processed in parallel, following which the standard curve
was used to determine the total concentration of indoles in the
sample. Concentrations were corrected for the sample dilution
factor.
RESULTS
STUDY POPULATION AND CHARACTERISTICS OF ENDOCERVICAL
INFECTION
Seventy-five women were recruited into the study and sam-
ples from 37 women were included in the final analyses; 29
women were excluded because they were C. trachomatis NAAT
and/or culture negative, and 9 were excluded because samples
were insufficient or could not be processed in a timely fash-
ion. The median age of the women with samples included
in the study was 22 years (range 18–30 years). Fourteen of
the women had mucopurulent cervicitis (MPC) (38%). Semi-
quantitative culture of C. trachomatis indicated infectious burden
in the endocervix varied considerably, with IFU per endocer-
vical swab ranging from 7 to 336,168 IFU (median 4802).
None of the women were positive for Neisseria gonorrhoeae,
but 3 (8.1%) were co-infected with T. vaginalis. Twenty-
one women (56.8%) were diagnosed with BV (Nugent score
7–10) and 7 (18.9%) had an intermediate (4–6) Nugent score
(Nugent et al., 1991).
IDENTIFICATION OF INTACT CHLAMYDIAL INCLUSIONS IN EPITHELIAL
CELLS HARVESTED FROM CERVICAL CYTOBRUSH SPECIMENS
We previously described the utility of cytobrushes for the
non-invasive and longitudinal retrieval of cervical lympho-
cytes (Ficarra et al., 2008). Here, we established that cytobrush
sampling can be used to harvest and enumerate C. trachomatis-
infected cervical epithelial cells. The original protocol was mod-
ified such that cytobrushes were immersed immediately upon
collection into liquid-based Pap test collection fluid. Bright-field
microscopy revealed epithelial cells in these samples retained their
characteristic morphology, permitting the detection of chlamy-
dial antigen and nucleic acid by fluorescence. DAPI staining
for DNA and immunofluorescent staining for chlamydial LPS
detected inclusions in 79.2% of samples (Figures 1A–C). The
median number of cells with inclusions in positive samples was
11 (range 2–50), with no correlation observed between inclusion
number and IFU (R2 = 0.08). Clusters of multiple infected cells
were often observed, and neutrophils frequently appeared to be
associated with the infected cells (Figure 2B). However, we note
that samples always included infected and uninfected “bystander”
cells (Figures 1C, 2B). In samples that had larger numbers of
cells, dual staining was performed using antibodies recognizing
chlamydial LPS and OmcA, a late cycle-expressed protein, or
chlamydial LPS with CT223, an inclusion membrane protein. We
observed that our results paralleled in vitro studies, with only EB-
size forms staining for OmcA (Figure 2A) and CT223 irregularly
distributed in a patchy “dash-like” distribution at the inclusion
surface (Figures 2B,C) (Alzhanov et al., 2009).
ULTRASTRUCTURAL ANALYSES OF CERVICAL INCLUSIONS PROVIDE
EVIDENCE FOR ABERRANT FORMS
The finding that immunofluorescence could be used to screen
for inclusion frequency in cervical samples encouraged us to
next develop a protocol that permitted a detailed ultrastructural
and molecular examination of these bacterial forms, along with
molecular studies of the cervicovaginal milieu. There were three
modifications of the sample collection protocol for the 13 women
enrolled into this component of the study. First, cytobrushes were
collected directly into a modified EM fixative; the formulation of
this fixative maintained the antigenic integrity of chlamydial LPS
and allowed visualization by standard IFA in samples processed
within 6 h of collection. This enabled us to screen samples by IFA
prior to processing for EM. Second, 25% of the endocervical swab
sample was immediately stabilized in MasterPure buffer in the
clinic. This enabled parallel analysis of chlamydial DNA and RNA
from the same sample used for determination of the IFU count.
Third, vaginal fluid was collected using an ophthalmic sponge for
quantification of IFNγ and indoles in these secretions.
A fraction (20%) of each cytobrush sample was screened
for the presence of inclusions by immunofluorescence using an
anti-chlamydial LPS antibody. Inclusions were detected by this
method in 5 of 13 samples, two of which had multiple (>10)
inclusions and were hence selected for further analyses. The
remaining 80% of the cytobrush for each of these two sam-
ples were processed for EM and scanned for inclusions. Using
this protocol, we were able to identify and examine three inclu-
sions in Patient 1 and five inclusions in Patient 2. There was a
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FIGURE 1 | Identification of chlamydial inclusions in endocervical cells
retrieved by cytobrush from C. trachomatis-infected women. Cytobrush
specimens immediately placed in (A) Surepath or (B,C) Cytolite were
processed as described in the methods, stained with anti-chlamydial
LPS-FITC (green), Evans blue (red) and DAPI (blue) and visualized by
fluorescent deconvolution microscopy. Note the morphology and staining
pattern in (A) suggests a single inclusion that is wrapped around the nucleus.
Scale bar is 5µm.
FIGURE 2 | Distribution of chlamydial LPS, OmcA, and CT223 in C.
trachomatis-infected epithelial cells harvested from human
endocervix. Cervical cells were dual-labeled with anti-chlamydial LPS
(green) and (A) OmcA (red) or (B) CT223 (red), counterstained with
DAPI (blue) and visualized by fluorescence deconvolution microscopy, as
described in the methods. Colocalization of antigen is visualized in
yellow. Scale bar is 5µm. Image (C) is a 3-dimensional maximum
intensity projection extracted from a deconvolved stack of an infected
cell in image (B). Note the irregular “dashed line” membranous staining
of CT223. Grid is 1µm.
striking difference in the morphology of bacterial forms in the
inclusions from these two subjects. Two EM images from Patient
1 are shown in Figures 3A,B. The morphological characteris-
tics in the third inclusion were similar to these two inclusions.
Each image displays the inclusion cross-sectional area, within
regions indicated by the green arrowheads magnified. A graph
indicating the distribution of particle sizes (as area) is also
shown. Inclusions from Patient 1 had an area of approximately
13–14µm2, with 25–40 “particles” within them. The average
area for each particle was approximately 0.15µm2. Particles were
sized by area rather than diameter because some of them were
shaped irregularly. The area of an EB (diameter 0.2–0.3µm)
is anticipated to be in 0.07–0.12µm2. The area within an RB
(diameter 0.7–1µm) is expected to be about 0.4–0.8µm2 (Ward,
1983; Wyrick, 2010). Particle analyses indicated that the parti-
cles within inclusions from Patient 1 were skewed toward the
area of an EB. The morphology of the particles within these
inclusions is indicated in the particles highlighted by the green
Frontiers in Cellular and Infection Microbiology www.frontiersin.org June 2014 | Volume 4 | Article 71 | 5
Lewis et al. Chlamydia trachomatis in human endocervix
FIGURE 3 | Ultrastructural images of inclusions from the cervix of a
single C. trachomatis patient. (A) An inclusion-containing electron
micrograph from Patient 1, processed and analyzed as described in the
Materials and Methods section. The entire micrograph is shown in the large
image on the left, with the scale bar indicating a distance of 1µm. The
smaller image on the right is a magnified view of the features indicated by
the green arrow. For this image, the scale bar indicates a distance of
0.5µm. Mature and immature EBs can be observed in the magnified view.
Quantification of the inclusion and its contents is indicated below the
image. The inclusion area was 13.23µm2. Forty EBs, RBs, and atypical RBs
were counted as particles within the inclusion, with an average particle area
of 0.14µm2. The plot indicates the frequency distribution of particles sized
(Continued)
FIGURE 3 | Continued
by their cross-sectional areas. The anticipated cross-sectional areas for EBs
and RBs are indicated in the frequency plot. The plot indicates the
frequency distribution of particles sized by their areas. (B) A second
inclusion-containing electron micrograph from Patient 1, processed and
analyzed as described above. The smaller image on the right indicates a
magnified view of the area highlighted by the green arrowhead on the
larger image. Two EBs and two RBs can be observed in the magnified view.
Quantification of inclusion area, particle area, and particle area frequency
distribution indicates the characteristics of this inclusion to be very similar
to those in (A).
arrowheads. Electron dense EBs, immature EBs, and RBs were
observed.
EM images from five unique inclusions were obtained from
Patient 2. The entire inclusion cross-sectional area was not
obtained for the first inclusion by EM, preventing calculation of
all parameters used for the other inclusions. EB morphotypes
predominated in this inclusion (Supplementary Figure 1). The
second inclusion is shown in Figure 4A. The inclusionmembrane
was difficult to visualize for this inclusion; therefore inclusion
area was calculated by subtracting a mask created using cytoplas-
mic/nuclear pixel density. The area of this inclusion, 26mm2, was
larger than the areas for inclusions from Patient 1. Particles within
this inclusion displayed the morphological characteristics of EBs,
immature EBs, and RBs. Some atypical/abnormal RBs (ABs) dis-
playing unequal binary fission were also observed. The average
particle area within this inclusion was 0.21µm2, reflecting a larger
number of RBs than the inclusions shown in Figure 3. The other
three inclusions from this patient (Figures 4B–D) displayed sim-
ilar characteristics to each other. They contained a large number
of RBs/ABs, with very few EBs, reflected in an average particle
area of 0.68µm2. The green arrowhead in Figure 4B indicates
particles with RB and EB morphology. While many RBs dis-
played equal binary fission, some abnormal binary fission events
were also observed. The micrograph shown in Figure 4C contains
three inclusions indicated by the large black arrowheads, two of
which are within the same cell. The third inclusion may also be
within that cell. While inclusion areas for the first two inclusions
were determined by automatic thresholding, the area for the third
inclusion was determined by manually outlining the inclusion.
The largest inclusion contained EBs, RBs, and several ABs, as eval-
uated by particle area. No EB sized particles were observed in the
two smaller inclusions. The average area for particles within these
three inclusions was skewed toward RBs. As classified by area, sev-
eral atypical RBs were observed in all three inclusions. The fifth
inclusion from this patient is shown in Figure 4D. The morpho-
logical characteristics of this inclusion resemble those observed
for the inclusions shown in Figures 4B,C. This inclusion con-
tained a few EB-sized particles (green arrowhead), although these
particles did not have the electron density of mature EBs, or the
electron dense core observed in immature EBs. Multiple RBs, as
exemplified by the red arrowhead were also observed. The aver-
age particle area was skewed toward RBs (0.58µm2), and several
ABs, as defined by large area and unequal binary fission events
were observed. While this analysis was performed with limited
numbers of inclusions, we note there is a statistically significant
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A B
C D
FIGURE 4 | Ultrastructural images from the cervix of a second
C.trachomatis infected patient. (A) An inclusion-containing electron
micrograph from Patient 2, processed and analyzed as described for Figure 3.
The entire micrograph is shown in the large image on the left, with the scale bar
indicating a distance of 1µm. The smaller images on the right are magnified
viewsof the features indicatedby thegreen (upper image) and red (lower image)
arrows. For these images, the scale bar indicates a distance of 0.5µm. The area
indicated by the green arrowhead contains an EB, and an RB. The area indicated
by the red arrowhead contains an RB undergoing binary fission. Quantification
of the inclusion and its contents is shown below the images. The inclusion area
was 26.57µm2. Sixty-two EBs, RBs, and atypical RBs were counted as
particles within the inclusion, with an average particle area of 0.21µm2. The
plot indicates the frequency distribution of particles sized by their
cross-sectional areas. The anticipated cross-sectional areas for EBs and RBs
are indicated in the frequency plot. (B) A second inclusion-containing electron
micrograph fromPatient 2. The smaller image on the right indicates amagnified
view of the area highlighted by the green arrowhead on the larger image. A RB
and an EB-sized particle can be observed in the magnified view. Quantification
of inclusion area, particle area, and particle area frequency distribution indicates
the characteristics of this inclusion to differ significantly the inclusion shown in
(A) or Figure 3. Very few particles with the area of an EB were observed. The
average area, 0.68µm2, was skewed toward the anticipated area of a RB, with
several larger particles also observed. (C) A third inclusion-containing electron
micrograph from Patient 2. Three inclusions were observed in this micrograph,
indicated by the large black arrows, at least two of which are within the same
cell. The largest inclusion contained particleswith the characteristic area of RBs
and EBs, as highlighted by the green arrow, and displayed in the upper image on
the right. The two smaller images contained particles with areas corresponding
to those of RBs, as highlighted by the red arrow, and displayed in the lower
image on the right. Quantification of the three inclusions is indicated below. The
largest inclusion had an area of 26.68µm2, whereas the smaller inclusions had
areas of 5–6µm2. The average area of particles within these three inclusions
was similar to that observed in (B), and distinct from the observations in (A). (D)
A fourth inclusion-containing micrograph from Patient 2. The characteristics of
this inclusion are close to those observed for the inclusions in (B,C). The green
arrowhead indicates particles with the area of EBs (upper magnified image on
the right), while the red arrowhead indicates a particle with the area of an RB
(lower magnified image on the right). Similar to the inclusions seen in (B,C), the
particles within this inclusion were skewed toward the size of RBs, with an
average area of 0.58µm2.
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difference in intra-inclusion particle size between Patients 1 and
2 (Supplementary Figure 2). The mixture of a few EBs, RBs,
and ABs observed in Figures 4B–D are reminiscent of inclusion
morphology observed in vitro when infected cells are exposed to
IFNγ . They also differ strikingly from inclusions observed after
penicillin exposure, which contain a single large RB (Skilton et al.,
2009), or after adenosine exposure, the latter being largely empty
with a few EBs (Pettengill et al., 2009).
Interestingly, particles with greater than EB-sized cross-
sectional areas observed within inclusions from Patient 2 appear
to display two types of binary fission characteristics (Figure 5).
Some of them (Figures 5A–C) displayed roughly equal binary
fission. However, several others (Figures 5D–F) displayed appar-
ently unequal binary fission. Some fission events with apparently
multi-septated ABs were also observed (Figures 5G,H). Because a
decreased expression of chlamydial genes required for cytokine-
sis is observed during IFNγ -induced persistence in vitro (Byrne
et al., 2001; Belland et al., 2003a), it is possible that the latter
events may result from the effects of IFNγ .
PARALLEL MOLECULAR ANALYSIS OF CERVICAL SPECIMENS WITH
ULTRASTRUCTURAL DATA IDENTIFIES A PATIENT WITH A BACTERIAL
PROFILE CONSISTENT WITH PERSISTENT GROWTH FORMS
A substantial body of indirect evidence supports the possibility
thatC. trachomatis adapts, and survives long-term, during human
infection (Hogan et al., 2004; Brunham and Rey-Ladino, 2005;
Wyrick, 2010). However, direct proof that the bacterium can enter
into a persistent mode of growth in human infections requires
FIGURE 5 | Examples of RB binary fission detected in electron
micrographs from Patient 2. Three types of binary fission were observed,
including, septum formation where the plane of division, indicated by a
green arrowhead, is predicted to result in equal division (A–C), or unequal
division (D–F), or where multiple septum formation events, indicated by the
red arrowheads, were apparently present (G–H). The scale bar indicates a
distance of 0.5µm.
morphologic evidence of aberrant forms to be substantiated by
molecular evaluation of bacterial growth patterns to determine
if the latter coincide with patterns observed in vitro. As our sec-
ond study protocol was designed to harvest, and immediately
preserve, parallel ex vivo endocervical samples for EM, nucleic
acid, and infectious particle (IFU) analyses, we next examined
multiple parameters of chlamydial growth in the 2 patients for
whom we had ultrastructural inclusion data. First, we observed
the two patients greatly contrasted in their IFU burden; Patient
1 had an IFU of greater than 336,168 and Patient 2 an IFU of
67 (Table 1). The median IFU in this patient population was
4802; thus, these two patients represent cases at the very high-
est, and at the lower end, of the spectrum of young women with
NAAT and culture-positive infections. Second, using total nucleic
acid derived from the same endocervical sample used to generate
IFU values, we enumerated genome copy numbers. Importantly,
both patients had high genome copy numbers despite the strik-
ingly lower IFU counts in Patient 2 whose genome copy number
actually exceeded that of Patient 1 (Table 1). These data indicate
that, relative to Patient 1, a significantly smaller proportion of
the total bacterial burden were infectious EB particles in Patient
2. Third, we evaluated the relative RNA expression levels of euo,
an early-expressed chlamydial gene that codes for Euo (Zhang
et al., 1998), and omcB, a gene expressed later in the develop-
mental cycle that is repressed by Euo (Rosario and Tan, 2012).
The ratio of euo to omcB mRNA expression also indicated con-
trasting patterns of growth in the two patients, with a significant
predominance of omcB transcripts in Patient 1 and a significant
predominance of euo transcripts in Patient 2 (Table 1). These
data taken together with the morphological evidence, suggests
that endocervical infection in both patients is characterized by a
heavy bacterial genome burden, but, in contrast to the highly pro-
ductive growth of Chlamydia in patient 1, the chlamydial growth
profile of patient 2 is relatively asynchronous, and predominated
by aberrant and early stage bacterial forms.
IFNγ AND INDOLES IN SECRETIONS IDENTIFY POTENTIAL
CORRELATES FOR DIFFERING CHLAMYDIAL GROWTH PATTERNS
BETWEEN PATIENTS
Next, we examined the infecting ompA genotype, clinical his-
tory, and key immune and environmental elements that might
explain the contrasting growth patterns seen in Patient 1 and
Patient 2. We determined that both patients were infected with
an identical E ompA genotype (data not shown), neither had a
Table 1 | Measurement of multiple parameters of growth of
C. trachomatis isolated from the cervix of two infected patients.
Growth parameter Patient 1 Patient 2
IFU 336,168 67
Genome copy number 359,002 895,313
Genome copy number: IFU 1.067924 13,362.88
Euo: omcB 1.865 10.0
Shown are total cervical infectious forming units (IFU), genome copy numbers,
ratio of IFU to genome copy number and ratio of Euo to omcB mRNA recovered
from an endocervical swab for each patient.
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documented history of C. trachomatis infection and both had a
mucopurulent cervical discharge but no vaginal discharge. Both
were negative for N. gonorrhoea and T. vaginalis but had a posi-
tive Nugent score (8 for Patient 1 and 7 for Patient 2, respectively)
indicating BV. Finally, we assayed genital secretions to reveal the
local concentration of indoles, and IFNγ . Indoles were detected
in both patients, with the levels in Patient 1 being approximately
twice as high as those in Patient 2 (278 vs. 159mM). Importantly,
while Patient 1 had a very low local concentration of IFNγ , this
response was robust in Patient 2 (1.45 vs. 68.95 pg/mg protein,
35.48 vs. 613.09 pg/ml) (Aiyar et al., 2014).
DISCUSSION
In this study, we sought to develop techniques to identify the
growth forms of C. trachomatis present in the human endo-
cervix, the most common site of infection in women, with the
concurrent evaluation of other biomarkers that could aid in
classifying the spectrum of infections that occur at this site.
During the course of this study, we established methodology
to preserve bacteria and host epithelial cells for detailed mor-
phologic and molecular analyses. This novel approach allowed
us to document the presence of inclusions containing normal,
morphologically aberrant, or a combination of these chlamy-
dial forms, in epithelial cells. Importantly, in a pilot study,
we could identify two patients with high numbers of bac-
terial genomes in their cervices, but, with contrasting bac-
terial growth patterns as revealed by parallel measurements
of IFU, inclusion morphology, and transcriptional analyses of
key early and late expressed chlamydial genes. Specifically, one
patient (Patient 1) had a chlamydial growth pattern predom-
inated by high numbers of infectious particles, whereas the
other (Patient 2) displayed a very low IFU with inclusions
that predominantly included both aberrant and normal RB
forms. Coincident with these observations, a minimal IFNγ
response was detected in Patient 1 secretions, in contrast to a
more robust IFNγ response in Patient 2. A significant level of
indoles was detected in both patients, likely consistent with being
BV-positive.
Relatively few studies have described the morphology and
abundance of chlamydial inclusions in the human cervix. In 1938,
Braley examined cervical biopsies and conjunctival smears from
respective mother-infant pairs in which the infant was diagnosed
with inclusion blennorrhea (Braley, 1938). Inclusions were read-
ily identified by Giemsa staining in infant conjunctival epithelial
cells, but were only found in the cervix of a small proportion
of women and were few in number (ibid). Three decades later,
using EM on biopsied transition zone and adjacent cervix in
two women co-infected with C. trachomatis and N. gonorrhoeae,
Swanson identified inclusions in the transitional zone and in
the columnar epithelium (Swanson et al., 1975). Of note, only
classical inclusions were investigated and described, and antigen-
specific staining procedures were not undertaken. Subsequent
endocervical infection studies predominantly focused on diag-
nostics (presence/absence of EB). Exceptions to this were a study
by Dunlop et al. who report observing chlamydiae in 7/159
patients by EM and present amicrograph of a single normal inclu-
sion (Dunlop et al., 1989), and a study by Bragina et al., who
reported the presence of small, aberrant bacterial forms in a cer-
vical smear of a patient after inappropriate antibiotic treatment
(Bragina et al., 2001). In vivo identification of human infections
with persistent C. trachomatis forms is clinically important as
these could: (1) provide a reservoir of persistent bacteria that
reactivate when conditions in the local micro-environment are
permissive; (2) evade key pathways involved in immune clearance;
(3) contribute to the chronic inflammatory process; (4) underlie
the recalcitrance of chlamydiae to clearance by certain antibi-
otics; and (5) avoid elimination by vaccine-induced immunity
optimized to eradicate replicating forms.
In the study described here, we were able to demonstrate the
utility of cytobrushes to sample intact infected cells from endo-
cervix, finding similar numbers of inclusions to those observed
in adult conjunctival smears (Braley, 1938). This methodology
is important as cytobrushes (i) are non-invasive, unlike biopsies
that are extremely difficult to obtain at this site, (ii) provide a
method for longitudinally sampling, and (iii) can be immedi-
ately placed in a medium of choice for ex vivo analysis. Thus,
by immediate immersion of cytobrushes into a modified EM
buffer, we could preserve bacterial growth forms ex vivo for anal-
yses by widefield or EM. The subsequent EM studies provide the
first collection of micrographs of multiple in vivo inclusions. In
one patient examined, inclusions were relatively homogeneous,
predominantly contained EBs, and are therefore late in the devel-
opmental cycle. In contrast, in the second patient, we identified
inclusions with predominantly RBs, predominantly ABs, a mix of
RB and aberrant forms, a heterogeneous mix of mid-stage forms,
and a classical late stage inclusion containing EBs. This wide spec-
trum of inclusion morphology suggests the possibility of different
microenvironments in the same tissue in which factor/s driving
bacterial development or persistence could be spatially and/or
temporally variable.
The IFNγ -mediated host response to C. trachomatis infection
has been studied in depth. In human cells, IFNγ induces the
tryptophan-catabolizing enzyme IDO1 that catabolizes trypto-
phan to kynurenine (Shemer and Sarov, 1985; Byrne et al., 1986,
1989; Carlin et al., 1989; Beatty et al., 1994a; Brunham and Rey-
Ladino, 2005). This depletion interferes with the growth of C.
trachomatis, which is a tryptophan auxotroph (ibid). At sufficient
and sustained concentrations of IFNγ in vitro, C. trachomatis can
be eliminated from human host cells establishing this cytokine
as a key component in local host defense (Byrne et al., 1989). In
tryptophan-limiting but sub-inhibitory concentrations of IFNγ
in vitro however, a scenario likely often encountered in vivo,
chlamydiae enter into the persistent mode of growth (Beatty et al.,
1993, 1994a). Transcriptome analysis of this altered state reveals
a gene expression profile consistent with continued expression
of genes governing DNA replication but not with those genes
involved in bacterial cell division (Belland et al., 2003a). This
includes upregulation of genes involved in tryptophan utiliza-
tion, DNA repair and recombination, phospholipid biosynthesis
and translation (ibid). A number of early genes are also upregu-
lated, and in particular, euo (30-fold increase), which encodes a
DNA-binding protein that binds to a late gene promoter region
and is the transcriptional regulator of omcB (Zhang et al., 1998,
2000; Rosario and Tan, 2012). Down-regulation of genes involved
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in RB to EB differentiation (such as omcAB), proteolysis, pep-
tide transport, and cell division are also noted (Belland et al.,
2003a). Removal of IFNγ leads to a rapid reactivation with gene
expression rapidly returning to control levels, for example, euo
expression drops 20-fold in 12 h (ibid). The knowledge that euo
and omcB are differentially expressed in active and IFNγ -driven
persistent growth, the commonality of this expression pattern
to other persistence inducers, their lack of co-expression and
the known stability of both mRNAs, all suggested the utility of
choosing euo/omcB expression ratio as a putative biomarker of in
vivo growth. By calculating this ratio, we were able to corrobo-
rate morphological, IFU, and genome data that the two patients
described in the study had contrasting patterns of chlamydial
growth. Future studies should confirm the utility of this combina-
tion of biomarkers to detect and determine the consequences of
a spectrum of C. trachomatis infection seen in the human endo-
cervix. Transcriptional analyses of a wider panel of genes should
also reveal the common inducers of persistence in the genital
tract. IFNγ is likely to be one of these stressors, and our lab-
oratory and others have identified a clear association with, but
spectrum of, IFNγ concentration in genital secretions during
C. trachomatis infection that wanes after resolution of infection
(Ficarra et al., 2008; Aiyar et al., 2014). Certainly the transcrip-
tional changes that occur in the presence of IFNγ and result
in persistent growth appear to constitute a persistence stimulon
and suggest a coordinated biological response that has evolved to
allow the organism to rapidly respond to, and survive, immuno-
logical pressure by a period of resistance followed by a rapid
recovery after waning of the host response or by supplementation
of tryptophan (Belland et al., 2003a). Importantly, by express-
ing tryptophan synthase during tryptophan starvation genital C.
trachomatis serovars can uniquely salvage indole to supplement
tryptophan, and indole-producing organisms such as bacteria
associated with BV and T. vaginalis have been suggested to be the
enabling co-factors (Caldwell et al., 2003; Morrison, 2003; Aiyar
et al., 2014). In support of this, both patients in this pilot study
were diagnosed with BV and indoles were present in their vagi-
nal secretions. We speculate that the weak IFNγ response noted
in Patient 1 may have been further compromised by indoles. In
contrast, the lower levels of indoles detected in Patient 2 may be
insufficient to overcome the restriction imposed by a robust IFNγ
response.
While undoubtedly challenging, human studies targeted at
elucidating if, when and how C. trachomatis enters into a persis-
tent growth mode in vivo has been repeatedly stressed as a priori
since these will likely significantly deepen our knowledge of the
pathogenesis of this disease and hence stimulate new targeted
treatment and prevention strategies (Wyrick, 2010; Schoborg,
2011). Because BV and T. vaginalis co-infections are so preva-
lent in C. trachomatis infected women (Koumans et al., 2007;
Sutton et al., 2007), the role they play in supplementing local
tryptophan, compromising IFNγ -mediated immunity and aid-
ing establishment of chronic infections is also critical (Caldwell
et al., 2003; Aiyar et al., 2014). The approaches described here
could be applied to evaluate chlamydial infections at other sites
in vivo. Further, as the commitment to a vaccine grows, we must
also consider the multiple implications of our, and other recent,
findings. Importantly, if the community is unable to develop a
sterilizing vaccine, then we will likely need to formulate a vaccine
to include antigens that are predominantly expressed by persistent
growth forms. In addition we will need to determine the type of,
and local level, of immunity and environmental milieu that will
be most effective at eradicating, and least likely to drive bacte-
ria into, a persistent growth mode, or to cause tissue damage. We
believe these studies, and the potential biomarker panel we have
investigated, form a strong platform for beginning to answer these
questions. They also provide an avenue to explore the effect, and
consequences of genital co-infections on C. trachomatis survival
in vivo.
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SUPPLEMENTARY MATERIAL
The Supplementary Material for this article can be found online
at: http://www.frontiersin.org/journal/10.3389/fcimb.2014.
00071/abstract
Supplementary Figure 1 | Ultrastructural image of an inclusion from
Patient 2. The entire inclusion cross-sectional area was not obtained for
this inclusion and therefore quantitative measurements were not
performed. EB morphotypes predominated in this inclusion.
Supplementary Figure 2 | Upper Panel: Particle cross-sectional area
(Y-axis) for every particle detected in the two inclusions from Patient-1
(Figure 3 in the manuscript). Particle identity was assigned in numerical
sequence by Fiji (X-axis). Particle cross-sectional area was calculated as
described in the Materials and Methods section. The light green shading
indicates the anticipated area for EBs, while the anticipated area for RBs
is shaded in light blue. Lower Panel: Particle cross-sectional area for
particles from the four inclusions from Patient-2 shown in Figure 4 of the
manuscript. The average cross-sectional area for particles from Patient-1
was 0.126 ± 0.109µm2, while the average cross-sectional area for
particles from Patient-2 was 0.431 ± 0.373µm2. The difference in particle
cross-sectional areas within inclusions from Patient-1 and Patient-2 was
determined to be statistically significant by the Wilcoxon rank-sum test:
P(two-sided) = 10e-16.
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